Table 4 The characteristics of the included systematic reviews regarding Guillen-Barre syndrome in COVID-19 infection
From: Neurological manifestations of COVID-19 infection: an umbrella review
Authors | Origin | Type | Quality | Number of included studies | Types of included studies | Assessing the quality of included studies | Searched databases | Main results |
|---|---|---|---|---|---|---|---|---|
1. Carrillo-Larco et al. 2020 [64] | Europe | Systematic review | Critically low | 8 | Case series, case report | None | Embase, Scopus, Web of Science, Global Health, Medline, MedRvix | Basic evidence suggests that GBS1 occurs after COVID-19 onset |
2. Gittermann et al. 2020 [68] | Chile | Systematic review | Low | 24 | Case series, case report | NHLBI2 tool | Pubmed, Cochrane Library, Science Direct, Medline, WHO search tool | There seem to be a strong association between the GBS and Covid-19 which differs in presentations, including the severity of the GBS manifestations |
3. Uncini et al. 2020 [65] | Europe | Systematic review | Critically low | 33 | Case series, case report | None | Pubmed | Classical GBS is presented in Covid-19 patients |
4. Hasan et al. 2020 [67] | Bangladesh | Systematic review + meta-analysis | Low | 45 | Case series, case report, cross sectional | JBI3 tool | Pubmed, Web of Science, Cochrane Library, Web of Science | An association exists between classic GBS and Covid-19. These manifestations are responsive to GBS standard treatments |
5. Abu-Rumeileh et al. 2020 [66] | Germany | Systematic review | Critically low | 52 | Case series, case report, reviews with case reports, reviews, letters, original article, point of view, and brief report | None | Pubmed, Google Scholar | COVID-19-associated GBS seems to share most features of classic post-infectious GBS with possibly the same immune-mediated pathogenetic mechanisms |